Package 70771-1601-7

{"route": ["INTRAVENOUS"], "spl_id": "f1081c30-3025-42ce-b222-824630689bb8", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316", "1665057"], "spl_set_id": ["cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 CARTON in 1 CARTON (70771-1601-7)  / 5 VIAL in 1 CARTON (70771-1601-5)  / 2 mL in 1 VIAL (70771-1601-1)", "package_ndc": "70771-1601-7", "marketing_start_date": "20201022"}], "brand_name": "Verapamil Hydrochloride", "product_id": "70771-1601_f1081c30-3025-42ce-b222-824630689bb8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70771-1601", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214215", "marketing_category": "ANDA", "marketing_start_date": "20201022", "listing_expiration_date": "20261231"}